RICHARDSON, Texas, July 11 /PRNewswire/ -- Zyvex Corporation today
announced the addition of Dr. Rob Burgess as Vice President of Research &
Development, and the promotions of Dr. Patrick Howard to Director of
Worldwide Sales, and Taylor Cavanah to Product Manager.
Dr. Burgess has a strong background in Life Sciences with a particular
focus in molecular biology, in vivo drug target validation, and genetic
engineering. He was formerly the Director of Scientific Sourcing and New
Technologies at Serologicals Corporation, a 1000-employee bio tools and
reagents company that realized $275M in 2005 revenue. There he provided
long- term visionary guidance for the company through the establishment of
key relationships and partnerships with academic researchers and
Burgess holds a B.A. in Biochemistry from the University of Texas at
Austin and a Ph.D. in Molecular Biology from the University of Texas, M.D.
Anderson Cancer Center in Houston. He has received numerous awards,
including an appointment to the Governor's Blue Ribbon Steering Committee
for the Southern California Life Sciences Summit and was a Visiting Scholar
at Georgia Tech University.
"We're excited to have Rob on our team," said Jim Von Ehr, CEO of
Zyvex. "His executive ability, people skills, planning skills, and energy
level are exactly what we're looking for. He also possesses outstanding
technology development skills and has a proven track record in growing
Dr. Patrick Howard joined the company in May 2006, as Worldwide Sales
Manager. He leads the company's global sales efforts, leveraging Zyvex's
strong technical position and customer-driven focus. Howard was formerly
President and CEO of TA Instruments, a Laboratory Instrumentation Company
in New Castle, Delaware with $65M in revenues. He holds an M.S. and Ph.D.
in Chemistry from the University of Houston and completed his undergraduate
work at Texas A&M University in Kingsville, Texas.
Taylor Cavanah joined Zyvex in 2004 and was formerly a Physicist and
Technical Sales Representative for Zyvex's NanoWorks(R) Tools product line.
He has experience dealing with worldwide customers in the areas of
Semiconductors and Electronics with a focus on basic nanotechnology
research and the microelectronics industry. He holds a B.A. in Physics from
Rice University, and a M.S. in Physics from the University of Texas at
"We're delighted to recognize Pat and Taylor's accomplishments," said
Von Ehr. "They have done an outstanding job focusing the company on rapidly
developing, manufacturing, and distributing tools, products, and services
targeted to real-world applications."
These positions reflect Zyvex's continued worldwide expansion and
commitment to customer service and attaining revenues through product
sales, technology licensing, and commercial and government contracts.
About the Company
Zyvex Corporation, based in Richardson, Texas, is the first molecular
nanotechnology company. Zyvex's vision is to be the leading worldwide
supplier of tools, products, and services that enable adaptable,
affordable, and molecularly precise manufacturing. Zyvex commercializes
nanotechnology to address real-world applications with high growth
potential. Zyvex carries its scientific breakthroughs into key commercial
applications in the area of materials, tools, and structures.
In addition to North America, Zyvex has worldwide sales representation
in Australia, China, France, Germany, Italy, Japan, Korea, Malaysia, New
Zealand, Poland, Singapore, Spain, Switzerland, Taiwan, Thailand, the
United Kingdom, and Vietnam through alliances with Keithley Instruments,
Inc., Caltron, Pte., Coherent Scientific Pty Ltd., and L.O.T.-Oriel.
For more information, contact Katharine Green, Director of Corporate
Communications, at email@example.com or by phone at 972.792.1620.
SOURCE Zyvex Corporation